Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CORE
1076
DELISTED
Core Mark Holding Co., Inc.
CORE
| $16.7M | 0.01% |
420,402
+149,402
| +55% | +$5.62M |
|
|
UFS
1077
DELISTED
DOMTAR CORPORATION (New)
UFS
| $16.7M | 0.01% |
374,942
+26,800
| +8% | +$1.22M |
|
|
UNVR
1078
DELISTED
Univar Solutions Inc.
UNVR
| $16.7M | 0.01% |
756,702
+625,169
| +475% | +$13.7M |
|
1079
CBIZ
CBZ
$2.96B
| $16.6M | 0.01% |
848,226
+8,800
| +1% | +$176K |
|
1080
PTC Therapeutics
PTCT
$6.06B
| $16.6M | 0.01% |
369,060
-538,240
| -59% | -$21.3M |
|
1081
Landstar System
LSTR
$6.31B
| $16.5M | 0.01% |
152,840
+140,400
| +1,129% | +$15M |
|
|
CPL
1082
DELISTED
CPFL Energia S.A.
CPL
| $16.5M | 0.01% |
1,056,311
+21,125
| +2% | +$316K |
|
|
CNR
1083
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $16.5M | 0.01% |
2,824,600
+20,880
| +0.7% | +$116K |
|
|
DSPG
1084
DELISTED
DSP Group Inc
DSPG
| $16.4M | 0.01% |
1,143,494
+41,200
| +4% | +$594K |
|
1085
AGNC Investment
AGNC
$12.9B
| $16.4M | 0.01% |
975,629
-5,404,000
| -85% | -$93.9M |
|
1086
Quanex
NX
$1B
| $16.4M | 0.01% |
868,200
+75,600
| +10% | +$1.27M |
|
|
CO
1087
DELISTED
Global Cord Blood Corporation
CO
| $16.3M | 0.01% |
2,826,896
+29,396
| +1% | +$194K |
|
1088
Camtek
CAMT
$8.13B
| $16.3M | 0.01% |
1,933,465
+105,365
| +6% | +$972K |
|
1089
OR Royalties Inc
OR
$6.31B
| $16.3M | 0.01% |
1,564,085
+268,985
| +21% | +$2.86M |
|
1090
TriMas Corp
TRS
$1.41B
| $16.2M | 0.01% |
523,900
+71,400
| +16% | +$2.19M |
|
1091
Village Super Market
VLGEA
$627M
| $16.2M | 0.01% |
611,900
+36,700
| +6% | +$995K |
|
1092
Boot Barn
BOOT
$4.87B
| $16.2M | 0.01% |
454,200
+425,100
| +1,461% | +$12.8M |
|
|
CNR
1093
Core Natural Resources Inc
CNR
$4.71B
| $16.2M | 0.01% |
608,200
+189,600
| +45% | +$5.67M |
|
|
CMA
1094
DELISTED
Comerica
CMA
| $16.1M | 0.01% |
222,042
+173,895
| +361% | +$12.9M |
|
1095
Ciena
CIEN
$61.2B
| $16M | 0.01% |
390,074
-1,208,200
| -76% | -$46.5M |
|
1096
Titan International
TWI
$450M
| $16M | 0.01% |
3,280,300
+109,100
| +3% | +$594K |
|
1097
NewMarket
NEU
$8.59B
| $16M | 0.01% |
40,000
+13,200
| +49% | +$5.46M |
|
1098
Western New England Bancorp
WNEB
$282M
| $16M | 0.01% |
1,713,327
+28,118
| +2% | +$265K |
|
1099
Bankunited
BKU
$3.38B
| $16M | 0.01% |
473,900
-226,300
| -32% | -$7.8M |
|
1100
ICICI Bank
IBN
$107B
| $16M | 0.01% |
+1,269,950
| New | +$14.7M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.